0001567619-21-006960.txt : 20210325 0001567619-21-006960.hdr.sgml : 20210325 20210325163649 ACCESSION NUMBER: 0001567619-21-006960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20210325 DATE AS OF CHANGE: 20210325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karas Kevin R CENTRAL INDEX KEY: 0001522907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 21772869 MAIL ADDRESS: STREET 1: C/O NATIONAL RESEARCH CORPORATION STREET 2: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 4 1 doc1.xml FORM 4 X0306 4 2018-09-24 0 0000070487 NATIONAL RESEARCH CORP NRC 0001522907 Karas Kevin R C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 0 1 0 0 SVP Finance, CFO, Treas & Secy Common Stock 2018-09-24 4 S 0 3700 38.2286 D 10684 D Common Stock 2018-09-24 4 S 0 300 39.0583 D 10384 D Common Stock 2021-03-23 4 M 0 5334 18.80 A 15718 D Common Stock 2021-03-23 4 M 0 19313 13.17 A 35031 D Common Stock 2021-03-23 4 F 0 12735 45.55 D 22296 D Employee Stock Option (Right to Buy) 18.80 2021-03-23 4 M 0 5334 0 D 2024-01-07 Common Stock 5334 0 D Employee Stock Option (Right to Buy) 13.17 2021-03-23 4 M 0 19313 0 D 2025-01-06 Common Stock 19313 0 D The price in Column 4 is a weighted average. The prices actually ranged from $38.00 to $38.70, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. The price in Column 4 is a weighted average price. The prices actually ranged from $39.025 to $39.075, inclusive. This option became fully exercisable on January 7, 2019. This option became fully exercisable on January 6, 2020. /s/ Kevin R. Karas, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC 2021-03-25